The upregulation of CCR1 and CXCR6 and the downregulation of CXCR6 ligand (CXCL16) in cells other than MB-231, suggest that alternative chemokine-related axes may be involved in the trafficking of breast cancer cells to the bone marrow. The gene discussed is CXCR6; the disease is breast cancer.